Nanometrix

NanoMetrix is a biotechnology company specializing in high-resolution protein analysis using advanced nanopore sensing technology. Spun out from the University of Oxford and founded by Professor Hagan Bayley, the company develops platforms capable of detecting and characterizing individual protein molecules and their interactions in real-time. Their technology aims to revolutionize drug discovery, proteomics, and diagnostics by providing unprecedented sensitivity and detail in molecular analysis. NanoMetrix leverages the foundational principles of nanopore sensing to address the complexities of the proteome, including post-translational modifications. The company is currently in the development stage, focusing on commercializing its single-molecule detection platform for research and clinical applications.